NKGen Biotech Company
NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.
Technology:
Cell therapy
Industry:
Private
Headquarters:
Santa Ana, California, United States
Founded Date:
2017-01-01
Employees Number:
51-100
Funding Status:
Seed
Investors Number:
1
Total Funding:
11000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-12-17
Last Funding Type:
Seed
Register and Claim Ownership